The therapeutic potential of utrophin has also been exemplified by a study in which DMD iPSCs were corrected by Sleeping Beauty (SB) transposon-mediated overexpression of utrophin.250. The gene discussed is UTRN; the disease is Duchenne muscular dystrophy.